SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-21-041642
Filing Date
2021-08-11
Accepted
2021-08-11 16:16:30
Documents
50
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0621_biotech.htm   iXBRL 10-Q 413841
2 CERTIFICATION f10q0621ex31-1_biotech.htm EX-31.1 17611
3 CERTIFICATION f10q0621ex31-2_biotech.htm EX-31.2 16642
4 CERTIFICATION f10q0621ex32-1_biotech.htm EX-32.1 6779
5 CERTIFICATION f10q0621ex32-2_biotech.htm EX-32.2 7044
  Complete submission text file 0001213900-21-041642.txt   2905125

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE biot-20210630.xsd EX-101.SCH 41574
7 XBRL CALCULATION FILE biot-20210630_cal.xml EX-101.CAL 20741
8 XBRL DEFINITION FILE biot-20210630_def.xml EX-101.DEF 166593
9 XBRL LABEL FILE biot-20210630_lab.xml EX-101.LAB 317538
10 XBRL PRESENTATION FILE biot-20210630_pre.xml EX-101.PRE 174172
11 EXTRACTED XBRL INSTANCE DOCUMENT f10q0621_biotech_htm.xml XML 260795
Mailing Address 545 WEST 25TH STREET 20TH FLOOR NEW YORK NY 10001
Business Address 545 WEST 25TH STREET 20TH FLOOR NEW YORK NY 10001 8586920539
Biotech Acquisition Co (Filer) CIK: 0001825413 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39935 | Film No.: 211163619
SIC: 6770 Blank Checks